Medsafe Logo


INFORMATION FOR CONSUMERS

Home  |  Consumers  |  Health Professionals  |  Regulatory  |  Other  |  Hot Topics  |  Search

Consumer Medicine Information

ACLASTA®

5mg / 100ml solution for infusion
Zoledronic acid

What is in this leaflet

This leaflet answers some common questions about Aclasta.

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

The information in this leaflet was last updated on the date listed on the final page. More recent information on the medicine may be available.

You should ensure that you speak to your pharmacist or doctor to obtain the most up-to-date information on the medicine. You can also download the most up-to-date leaflet from www.medsafe.govt.nz

Those updates may contain important information about the medicine and its use of which you should be aware.

All medicines have risks and benefits. Your doctor has weighed the risks of you having Aclasta against the benefits they expect it will have for you.

If you have any concerns about having this medicine, ask your doctor or pharmacist.

Keep this leaflet. You may need to read it again.

What Aclasta is used for

The active ingredient in Aclasta is zoledronic acid, which belongs to a group of medicines called bisphosphonates.

Aclasta is used to treat pagets' disease of the bone, osteoporosis in men, treatment and prevention of osteoporosis in postmenopausal women, treatment and prevent of osteoporosis caused by treatment with steroid medicines, or to prevent additional fractures in patients who have recently had a hip fracture.

In Paget's disease, the bone material breaks down too much, new bone material grows too quickly, and in a disordered way. The bone material produced is weaker than normal. If the disease is not treated, bones may become deformed and painful, and may break. Aclasta works by returning the bone remodelling process to normal, and restoring strength to the bone.

Osteoporosis is a disease which causes bones to become less dense, gradually making them weaker, more brittle and likely to break. This is common in women after menopause, when a woman's ovaries stop producing the female hormone, oestrogen, which keeps bones healthy.. Broken bones may result from injury or simple falls. Breaks may occur during normal everyday activity, such as lifting, or from minor injury that would not ordinarily fracture normal bone. Fractures in people with osteoporosis usually occur at the hip, spine or wrist. These can lead not only to pain, but also to considerable deformity and disability, such as stooped posture from curvature of the spine, and loss of mobility.

Aclasta works by strengthening bones, making them less likely to break. Since it works for a long time, you will not need another dose for a year.

Ask your doctor if you have any questions about why this medicine has been prescribed for you.
Your doctor may have prescribed it for another reason.

Aclasta is only available with a doctor's prescription. It is not addictive.

There is not enough information to recommend the use of this medicine for children or adolescents.

Before you have Aclasta

When you must not have it

You must not have Aclasta if you have an allergy to:

Some of the symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; rash, itching or hives on the skin.

If you are not sure whether you are allergic to other bisphosphonate medicines, talk to your doctor.
Other bisphosphonate medicines have been shown to cause breathing difficulties in people with asthma who are allergic to aspirin.

Do not have Aclasta if you have low levels of calcium in your blood.
Your doctor may do a blood test to check your calcium levels before you have Aclasta.

Do not have Aclasta if you are pregnant.
There is no information on use of this medicine in pregnancy.

Do not breast-feed while you are having treatment with Aclasta.
It is not known if the active ingredient, zoledronic acid, passes into the breast milk and could affect your baby.

Do not have Aclasta after the expiry date printed on the pack or if the packaging is torn or shows signs of tampering.
If it has expired or is damaged, return it to your pharmacist.

If you are not sure whether you should be given this medicine, talk to your doctor.

Before you have it

Tell your doctor if

Taking other medicines

Tell your doctor, nurse or pharmacist if you are taking any other medicines, including medicines that you buy without a prescription from your pharmacy, supermarket or health food shop.

Some medicines and Aclasta can interfere with each other. These include:

You may need to take different amounts of these medicines or you may need to take different medicines. Your doctor or pharmacist has more information.

How Aclasta is given

Follow all directions given to you by your doctor, nurse and pharmacist carefully.
These directions may differ from the information contained in this leaflet.

If you do not understand the instructions, ask your doctor, nurse or pharmacist for help before treatment starts.

How it will be given

Aclasta will be given to you by infusion into a vein by your doctor or nurse once a year. The infusion will take at least 15 minutes.

If you had a recent hip fracture after a fall from a standing position or lower, a dose of 50,000 to 125,000 IU of vitamin D will be given to you orally or via the intramuscular route by your doctor or nurse prior to the first Aclasta infusion.

Make sure you drink enough fluids before and after the treatment with Aclasta as directed by your doctor.

Two glasses of fluid (such as water) before and after the infusion are usually enough. This will help to prevent dehydration.

You may eat normally on the day you are treated with Aclasta.

How much is given

A 100mL infusion will last at least 15 minutes.

How long treatment will last

Each dose of Aclasta lasts one year. Your doctor will check your condition and may prescribe further treatment.

If you have too much (overdose)

Immediately telephone your doctor or the National Poisons Information Centre (telephone 0800 POISON or 0800764766), or go to the Accident and Emergency department at your nearest hospital if you think that an overdose has happened. Do this even if there are no signs of discomfort or poisoning.

Tell your doctor if you have any of the following symptoms:

These symptoms may mean the level of calcium in your blood has fallen too far.

While you are being given Aclasta

Things you must do

Take paracetamol for the first three days if your doctor has told you to.
Some people get short-lasting flu-like symptoms after having Aclasta. Paracetamol can provide some relief.

Take calcium and vitamin D supplements if your doctor has told you to.
Most people do not get enough calcium and vitamin D in their diet and supplements are needed to help strengthen your bones.

Keep all of your doctor's appointments so that your progress can be checked.
Your doctor may want you to have X-rays, bone density scans or urine tests from time to time to make sure Aclasta is working and to prevent unwanted side effects from happening.

Tell your doctor immediately if you become pregnant while having treatment with this medicine.
Your doctor can discuss with you the risks of having it while you are pregnant.

Tell your doctor and dentist immediately about any dental symptoms including persistent pain and/or non-healing sores of the mouth or jaw.
A dental condition called jaw osteonecrosis has been reported, primarily in patients being treated with Aclasta or other bisphosphonates for other illnesses.

If you are about to be started on any new medicine, remind your doctor and pharmacist that you are being treated with Aclasta.

Tell any other doctor, dentist or pharmacist who treats you that you are having Aclasta.

Things to be careful of

Be careful driving or operating machinery until you know how Aclasta affects you.
Aclasta has no known effect on the ability to drive or use machines but, as a general precaution, if you are driving home after the infusion, arrange to have someone else drive.

Side effects

Tell your doctor or pharmacist as soon as possible if you do not feel well while you are having Aclasta.
All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical attention if you get some of the side effects.

Do not be alarmed by the following list of side effects. You may not experience any of them.

Ask your doctor or pharmacist to answer any questions you may have.

Tell your doctor or pharmacist if you notice any of the following and they worry you:

Tell your doctor immediately or go to Accident and Emergency at your nearest hospital if you notice any of the following after you have Aclasta:

The above side effects may be serious. You may need urgent medical attention.

Tell your doctor or pharmacist if you notice anything that is making you feel unwell.
Other side effects not listed above may also occur in some people. Some of these (e.g. effects on kidney function and on the level of calcium in the blood) can only be found by laboratory testing.

After having Aclasta

Storage

It is unlikely you will have to store Aclasta at home.

If you do have to store it:

Heat and dampness can destroy some medicines.

Keep the medicine where young children cannot reach it.
A locked cupboard at least one-and-a-half metres above the ground is a good place to store medicines.

Each Aclasta vial is to be used for one infusion only and then discarded.

Disposal

If you no longer need Aclasta or it has passed its expiry date, return any unused medicine to your pharmacist.

Product description

What it looks like

Aclasta solution for infusion is supplied in a transparent plastic vial containing 100mL of a clear, colourless solution. Aclasta is supplied as packs containing one vial.

Ingredients

Each vial of Aclasta contains 5mg of zoledronic acid. The vials also contain mannitol, sodium citrate and water for injections.

Sponsor

Aclasta is supplied in New Zealand by:

Novartis New Zealand Limited

Private Bag 65904
Mairangi Bay
Auckland
Building G, 5 Orbit Drive
Rosedale
Auckland 0632

Telephone 0800 652 422

Date of preparation

This leaflet was prepared on 8 October 2009 based on the current data sheet for this product.

® = Registered trademark